Table 1 Characteristics of peptides used in this study

CATH-1

RVKRVWPLVIRTVIAGYNLYRAIKKK

26

+ 8

CATH-2

RFGRFLRKIRRFRPKVTITIQGSARF

26

+ 9

CATH-3

RVKRFWPLVPVAINTVAAGINLYKAIRRK

29

+ 7

CATH-B1

PIRNWWIRIWEWLNGIRKRLRQRSPFYVRGHLNVTSTPQP

40

+ 7

CRAMP

GLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPEQ

34

+ 6

PMAP-36

GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG

36

+ 13

PR-39

RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP

39

+ 10